Faruqi & Faruqi Reminds Rocket Pharmaceuticals Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of August 11, 2025 - RCKT
Provided By PR Newswire
Last update: Aug 9, 2025
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Rocket Pharmaceuticals To Contact Him Directly To Discuss Their Options
Read more at prnewswire.comNASDAQ:RCKT (11/18/2025, 10:52:04 AM)
2.9654
-0.07 (-2.45%)
Find more stocks in the Stock Screener
RCKT Latest News and Analysis
12 days ago - By: Chartmill
